Austar Lifesciences' low P/S ratio may be a buying opportuni...
Austar Lifesciences' low P/S ratio may be a buying opportunity, but its poor financial performance and declining revenue are concerning. Despite higher medium-term revenue growth rates than the industry average, the continued decline in stock price and P/S ratio indicates potential risks.
![](https://pubimg-10000538.picsh.myqcloud.com/2022050900000260f61a00f7c22.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment